BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/7/2015 11:06:00 AM | Browse: 1167 | Download: 1530
 |
Received |
|
2014-06-20 09:11 |
 |
Peer-Review Started |
|
2014-06-20 16:19 |
 |
To Make the First Decision |
|
2014-07-21 14:07 |
 |
Return for Revision |
|
2014-07-28 16:18 |
 |
Revised |
|
2014-08-27 02:21 |
 |
Second Decision |
|
2014-09-30 10:03 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2014-09-30 10:29 |
 |
Articles in Press |
|
2014-09-30 10:56 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2014-12-24 21:05 |
 |
Publish the Manuscript Online |
|
2015-01-07 11:07 |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Observational Study |
Article Title |
Long-term follow-up of distal intestinal obstruction syndrome in cystic fibrosis
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Moran Lavie, Tzipora Manovitz, Daphna Vilozni, Sarina Levy-Mendelovich, Ifat Sarouk, Ilana Weintraubv, David Shoseyov, Malena Cohen-Cymberknoh, Joseph Rivlin and Ori Efrati |
Funding Agency and Grant Number |
|
Corresponding Author |
Dr. Moran Lavie, Pediatric Pulmonary Unit and the National Center for Cystic Fibrosis, Edmond and Lily Safra Children’s Hospital, Sheba Medical Center, Derech Sheba 2, Tel Hashomer 52621, Israel. moran.lavie@sheba.health.gov.il |
Key Words |
Distal intestinal obstruction syndrome; Cystic fibrosis; Meconium ileus; Treatment; Recurrence |
Core Tip |
Distal intestinal obstruction syndrome (DIOS) is a gastrointestinal complication of cystic fibrosis (CF). This study reviews the long-term follow-up of DIOS across two decades in Israeli CF patients. The DIOS patients were more prone to meconium ileus, Aspergillus spp. airway colonization and frequent hospitalizations then the DIOS-negative CF patients. DIOS recurrence was observed in 77% of patients. Conservative treatment was successful in 82% of the episodes, which makes it the treatment of choice for DIOS management. The survival rate was similar to the CF patients without DIOS. |
Publish Date |
2015-01-07 11:07 |
Citation |
Lavie M, Manovitz T, Vilozni D, Levy-Mendelovich S, Sarouk I, Weintraubv I, Shoseyov D, Cohen-Cymberknoh M, Rivlin J, Efrati O. Long-term follow-up of distal intestinal obstruction syndrome in cystic fibrosis. World J Gastroenterol 2015; 21(1): 318-325 |
URL |
http://www.wjgnet.com/1007-9327/full/v21/i1/318.htm |
DOI |
http://dx.doi.org/10.3748/wjg.v21.i1.318 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345